Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
2,435,040
-
Share change
-
-261,954
-
Total reported value
-
$2,477,698
-
Price per share
-
$1.03
-
Number of holders
-
10
-
Value change
-
-$373,142
-
Number of buys
-
4
-
Number of sells
-
6
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q1 2017
As of 31 Mar 2017,
Aptose Biosciences Inc. - Common Shares was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,435,040 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, ROYAL BANK OF CANADA, BANK OF MONTREAL /CAN/, RENAISSANCE TECHNOLOGIES LLC, JANE STREET GROUP, LLC, Federation des caisses Desjardins du Quebec, Parallax Volatility Advisers, L.P., MORGAN STANLEY, and Creative Planning.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.